8-K: NaturalShrimp shifts control, acquires IP

NaturalShrimp announces a change in control, new CEO, and a recapitalization tied to acquiring Hydrenesis aquaculture and water treatment IP.

Summary

• On March 17, 2026, NaturalShrimp entered into an Intellectual Property Acquisition and Management Transition Agreement with Hydrenesis, Inc. and David Antelo.
• Operations will transition toward commercialization of aquaculture and water treatment technologies with certain Hydrenesis IP transferred to NaturalShrimp.
• Approximately $1,034,112 owed to Hydrenesis will be converted into equity at Closing.
• New preferred stock series—Series L, Series P, and Series P-2—have been approved, with Certificates of Designation to be filed with the Nevada Secretary of State.
• Existing liabilities and legacy securities, including Series A and Series F Preferred Stock, will be restructured, amended, cancelled, or exchanged into Series L Preferred Stock.
• Unregistered sales of the new preferred securities will proceed under Section 4(a)(2) and/or Regulation D, subject to transfer restrictions.
• A change in control occurred via governance provisions granting control over board composition and executive authority, coupled with the recapitalization steps.
• Leadership changes include the resignation of the prior CEO, CFO, and COO/directors, and the appointment of David Antelo as Chief Executive Officer and sole director.
• The Board is expected to be expanded to three directors.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as moderately positive due to balance-sheet cleanup, governance reset, and IP infusion, tempered by dilution risk and execution uncertainty with limited financial visibility.

Positives

• Debt burden reduced via conversion of approximately $1,034,112 owed to Hydrenesis into equity.
• Strategic focus clarified: transition toward commercialization of aquaculture and water treatment technologies.
• Transfer of defined intellectual property and related technology assets from Hydrenesis provides a potential technology moat.
• Comprehensive recapitalization plan to simplify capital structure by restructuring/cancelling/exchanging legacy Series A and Series F Preferred Stock into Series L.
• Governance reset enables faster decision-making with new CEO and sole director, with intent to expand the Board to three members.

Negatives

• Significant dilution risk due to issuance of Series L, Series P, and Series P-2 Preferred Stock and conversion/exchange of legacy securities.
• Change in control introduces execution risk during the transition period.
• No financial performance metrics, revenue, liquidity, or profitability data provided.
• Key management turnover (CEO, CFO, COO) can disrupt operations despite stated lack of disagreements.

Risks

• Equity dilution from new preferred issuances (Series L, Series P, Series P-2) and exchanges of legacy preferred stock.
• Uncertainty around the terms and rights of the new preferred stock series pending the filing and effectiveness of Certificates of Designation.
• Execution risk tied to transitioning operations toward commercialization of aquaculture and water treatment technologies.
• Governance concentration risk with a sole director initially controlling board composition and executive authority until the Board is expanded.
• Regulatory and transfer restrictions on unregistered securities issued under Section 4(a)(2) and/or Regulation D could limit liquidity for holders.

Future Outlook

Management plans to pivot operations to commercialize aquaculture and water treatment technologies, integrate transferred Hydrenesis IP, complete preferred stock designations and issuances, restructure legacy securities into Series L, and expand the Board to three directors.

Management Comments

• Resignations of the prior CEO, CFO, and COO/directors were not due to disagreements regarding operations, policies, or practices.
• Board size is expected to increase to three directors following the initial appointment of a sole director.
• Governance provisions in the Agreement grant control over board composition and executive authority to support the transition.

Industry Context

StockSavvy.ai notes a familiar microcap turnaround pattern: a change in control combined with IP acquisition and recapitalization to reposition the business toward higher-value aquaculture and water treatment technologies. This aligns with broader trends in controlled-environment aquaculture and water tech where IP and process innovation are key differentiators, though successful execution typically requires additional capital and demonstrable operating metrics.

Comparison to Industry Standards

• Relative to microcap restructurings in agri-tech and water technology (e.g., leadership changes and recapitalizations at firms like AquaBounty Technologies and small-cap water treatment peers), the combination of debt-for-equity conversion and new preferred series is a common mechanism to clean up balance sheets and realign control.
• In the aquaculture technology space, credible commercialization updates often include KPIs such as survival rates, feed conversion ratio (FCR), biomass yield per cubic meter, and recurring revenue from technology licensing or system sales; none of these KPIs are provided, limiting benchmarking to sector norms.
• Water technology comparables (e.g., early-stage IP holders in electrochemical or advanced oxidation processes) typically disclose pilot-to-commercial progression milestones and gross margin targets; here, only structural and governance changes are disclosed, not margins or deployment scale, making outcome comparisons premature.

Management Changes

Corporate Governance

Stakeholder Impact

• Common shareholders face potential dilution from new preferred issuances and exchanges.
• Preferred holders of Series A and Series F are directly impacted by restructuring, cancellation, or exchange into Series L.
• Creditor Hydrenesis converts approximately $1,034,112 of obligations into equity, reducing debt and altering creditor mix.
• Employees and management undergo leadership transition, which can create short-term uncertainty but may streamline execution.
• Customers and partners may see a renewed focus on aquaculture and water treatment technology commercialization.
• Prospective investors encounter transfer-restricted, unregistered preferred securities that may have specific rights and preferences.

Next Steps

• File Certificates of Designation for Series L, Series P, and Series P-2 Preferred Stock with the Nevada Secretary of State and obtain effectiveness.
• Issue the new preferred securities pursuant to exemptions under Section 4(a)(2) and/or Regulation D with applicable transfer restrictions.
• Convert approximately $1,034,112 owed to Hydrenesis into equity at Closing.
• Restructure, amend, cancel, or exchange legacy Series A and Series F Preferred Stock into Series L Preferred Stock.
• Complete transfer of Hydrenesis intellectual property and related technology assets.
• Expand the Board from a sole director to three directors.

Key Dates

Recommendation

A strategic reset, debt-to-equity conversion, and IP acquisition are constructive, but dilution, concentrated governance, and lack of operating or financial detail warrant caution. Await specifics on preferred terms, board expansion, and a commercialization roadmap before changing positioning.

Keywords

NaturalShrimp, Hydrenesis, change in control, intellectual property acquisition, aquaculture technology, water treatment technology, Series L Preferred Stock, Series P Preferred Stock, Series P-2 Preferred Stock, debt-to-equity conversion, unregistered securities, Regulation D, Section 4(a)(2), management transition, board restructuring